Bell Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.93M Buy
78,616
+1,959
+3% +$258K 0.38% 41
2026
Q1
$10.7M Buy
76,657
+80
+0.1% +$11.2K 0.45% 35
2025
Q4
$9.4M Sell
76,577
-2,008
-3% -$244K 0.4% 38
2025
Q3
$8.72M Buy
78,585
+1,389
+2% +$158K 0.38% 42
2025
Q2
$8.56M Sell
77,196
-38,966
-34% -$4.15M 0.4% 40
2025
Q1
$13M Sell
116,162
-2,025
-2% -$209K 0.7% 20
2024
Q4
$10.9M Buy
118,187
+5,546
+5% +$499K 0.81% 17
2024
Q3
$9.44M Sell
112,641
-19,832
-15% -$1.51M 1.12% 18
2024
Q2
$9.09M Buy
132,473
+4,222
+3% +$282K 0.76% 21
2024
Q1
$9.39M Buy
128,251
+4,618
+4% +$355K 0.81% 18
2023
Q4
$10M Sell
123,633
-434
-0.3% -$33.8K 0.97% 13
2023
Q3
$9.3M Buy
124,067
+782
+0.6% +$60.1K 1.02% 11
2023
Q2
$9.5M Sell
123,285
-4,672
-4% -$373K 1.01% 11
2023
Q1
$10.6M Sell
127,957
-8,983
-7% -$744K 1.12% 11
2022
Q4
$11.8M Sell
136,940
-7,191
-5% -$569K 1.37% 11
2022
Q3
$8.89M Buy
144,131
+16,718
+13% +$1.05M 1.14% 15
2022
Q2
$7.88M Buy
127,413
+10,457
+9% +$647K 0.94% 21
2022
Q1
$6.95M Buy
+116,956
New +$7.48M 0.78% 30
2020
Q2
Sell
-20,040
Closed -$1.5M 155
2020
Q1
$1.5M Buy
+20,040
New +$1.38M 0.33% 42
2016
Q3
Sell
-2,507
Closed -$209K 124
2016
Q2
$209K Hold
2,507
0.12% 121
2016
Q1
$230K Buy
+2,507
New +$226K 0.15% 105

Other funds holding GILD

Bell Bank's GILD Position: Q2 2026 in Review

Bell Bank increased its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, buying an estimated $258K and bringing the position to 78,616 shares worth $9.93M. The position accounts for 0.38% of the portfolio, ranked #41.

Bell Bank first reported a position in GILD in Q1 2016 and has held it in 21 quarters since. The position peaked at $13M in Q1 2025. 366 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bell Bank held 78,616 shares of Gilead Sciences worth $9.93M as of Q2 2026.
  • Bell Bank bought 1,959 Gilead Sciences shares in Q2 2026, an estimated $258K.
  • Gilead Sciences made up 0.38% of Bell Bank's portfolio in Q2 2026, its #41 holding.
  • Bell Bank first reported a position in Gilead Sciences in Q1 2016 and has held it in 21 quarters since.
  • Bell Bank's Gilead Sciences position peaked at $13M in Q1 2025.
  • 366 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bell Bank's 13F filing for Q2 2026, filed 16 Jul 2026.